APA (7th ed.) Citation

Kumakech, E., Berggren, V., Wabinga, H., Lillsunde-Larsson, G., Helenius, G., Kaliff, M., . . . Andersson, S. (2016). Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda. PloS one, 11(8), e0160099. https://doi.org/10.1371/journal.pone.0160099

Chicago Style (17th ed.) Citation

Kumakech, Edward, et al. "Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections Among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years After a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda." PloS One 11, no. 8 (2016): e0160099. https://doi.org/10.1371/journal.pone.0160099.

MLA (9th ed.) Citation

Kumakech, Edward, et al. "Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections Among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years After a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda." PloS One, vol. 11, no. 8, 2016, p. e0160099, https://doi.org/10.1371/journal.pone.0160099.